Overview
Michael Rabin is an Oncologist practicing medicine in Boston, Massachusetts.
Dr. Rabin is highly rated in 15 conditions, according to our data. His clinical expertise encompasses EGFR Positive Lung Cancer, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and Lung Adenocarcinoma.
Dr. Rabin is board certified in Internal Medicine and Hematology. He is actively involved in clinical research, co-authoring 34 peer reviewed articles.
Graduate Institution
Residency
Specialties
Licenses
Board Certifications
Fellowships
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- EPO
- HMO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
450 Brookline Avenue, Boston, MA 02115
Additional Areas of Focus
Dr. Rabin has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Dana-Farber Cancer Institute
Matthew Davids is an Oncologist practicing medicine in Boston, Massachusetts. Dr. Davids is highly rated in 20 conditions, according to our data. His clinical expertise encompasses Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Small Lymphocytic Lymphoma (SLL), Bone Marrow Transplant, and Bone Marrow Aspiration.
Dana-Farber Cancer Institute
Daniel Deangelo is an Oncologist practicing medicine in Boston, Massachusetts. Dr. Deangelo is highly rated in 36 conditions, according to our data. His clinical expertise encompasses Systemic Mastocytosis, Acute Myeloid Leukemia (AML), Leukemia, Bone Marrow Aspiration, and Bone Marrow Transplant.
Massachusetts General Hospital
Jeremy Abramson is an Oncologist practicing medicine in Boston, Massachusetts. Dr. Abramson is highly rated in 28 conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, B-Cell Lymphoma, Classical Hodgkin Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration.
Frequently Asked Questions about Dr. Michael S. Rabin
How do I make an appointment with Dr. Michael S. Rabin?
You can book an appointment with Dr. Michael S. Rabin by calling their office at 617-632-6049. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Michael S. Rabin a top-rated expert for EGFR Positive Lung Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Michael S. Rabin is classified as an Elite expert for EGFR Positive Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Michael S. Rabin specialize in?
While Dr. Michael S. Rabin is a Oncology, they have specific expertise in EGFR Positive Lung Cancer, Lung Cancer, and Non-Small Cell Lung Cancer (NSCLC). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Michael S. Rabin participate in research or clinical trials?
Yes. Dr. Michael S. Rabin has published 34 articles and abstracts on conditions like EGFR Positive Lung Cancer. You can view a list of Dr. Michael S. Rabin's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Michael S. Rabin accept my insurance?
Dr. Michael S. Rabin accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 617-632-6049 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- EGFR Positive Lung CancerDr. Rabin isElite. Learn about EGFR Positive Lung Cancer.
- Lung CancerDr. Rabin isElite. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)
- Distinguished
- ALK-Positive Non-Small Cell Lung CancerDr. Rabin isDistinguished. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Large-Cell Lung CarcinomaDr. Rabin isDistinguished. Learn about Large-Cell Lung Carcinoma.
- Lung AdenocarcinomaDr. Rabin isDistinguished. Learn about Lung Adenocarcinoma.
- MesotheliomaDr. Rabin isDistinguished. Learn about Mesothelioma.
- Metastatic Pleural TumorDr. Rabin isDistinguished. Learn about Metastatic Pleural Tumor.
- Pleuropulmonary BlastomaDr. Rabin isDistinguished. Learn about Pleuropulmonary Blastoma.
- Advanced
- Metastatic Brain TumorDr. Rabin isAdvanced. Learn about Metastatic Brain Tumor.
- Experienced
- Lung NodulesDr. Rabin isExperienced. Learn about Lung Nodules.
- Neuroendocrine TumorDr. Rabin isExperienced. Learn about Neuroendocrine Tumor.
- Pseudomyxoma PeritoneiDr. Rabin isExperienced. Learn about Pseudomyxoma Peritonei.
- Renal OncocytomaDr. Rabin isExperienced. Learn about Renal Oncocytoma.